Interní Med. 2011; 13(7): 296-299

The potential of diet to affect atherosclerotic cardiovascular diseases

prof.MUDr.Vladimír Bláha, CSc., MUDr.Jakub Víšek, Ph.D.
Klinika gerontologická a metabolická, LF UK a FN Hradec Králové

The consumption of saturated fatty acids (SFAs) elevates the concentration of low-density lipoprotein (LDL) cholesterol in plasma

and contributes to an increased risk of ischemic heart disease (IHD). Reducing the occurrence of atherogenic dyslipidemia (includes

a higher content of small LDL particles, reduced HDL-C and increased triglycerides) can be achieved by lowering the consumption of

carbohydrates in the diet or by weight loss while altering the content of total or saturated fat has only minimal effect. A low-fat and

high-carbohydrate diet results in reduced concentrations of LDL-C compared to a high-fat and low-carbohydrate diet, particularly in

individuals with lipoprotein phenotype B. From what is mentioned above, it is not entirely clear which type of diet (whether one with

low or with high content of carbohydrates) is of greater benefit in terms of cardiovascular risk. Observational epidemiological and

randomized controlled studies evaluating the incidence of IHD have contributed to the establishment of dietary guidelines focused on

a controlled and restricted intake of SFAs in order to prevent IHD. Critically, it can be stated that evidence from cohort and randomized

controlled studies has its limitations.

Keywords: carbohydrates, cardiovascular disease, monounsaturated fatty acids, polyunsaturated fatty acids, saturated fatty acids

Published: October 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bláha V, Víšek J. The potential of diet to affect atherosclerotic cardiovascular diseases. Interní Med. 2011;13(7):296-299.
Download citation

References

  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421. Go to original source...
  2. Genest J Jr, McNamara JR, Ordovas JM, et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992; 19: 792-802. Go to original source... Go to PubMed...
  3. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104. Go to original source...
  4. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense lowdensity lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75. Go to original source... Go to PubMed...
  5. St-Pierre AC, Ruel IL, Cantin B, et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 2001; 104: 2295-2299. Go to original source... Go to PubMed...
  6. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363-1379. Go to original source... Go to PubMed...
  7. Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial. Am J Cardiol 2002; 90: 89-94. Go to original source... Go to PubMed...
  8. Asztalos BF, Collins D, Cupples LA, et al. Value of high density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial. Arterioscler Thromb Vasc Biol 2005; 25: 2185-2191. Go to original source... Go to PubMed...
  9. Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966; 34: 679-697. Go to original source... Go to PubMed...
  10. Stampfer MJ, Sacks FM, Salvini S, et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-381. Go to original source... Go to PubMed...
  11. Sweetnam PM, Bolton CH, Yarnell JW, et al. Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1994; 90: 769-774. Go to original source... Go to PubMed...
  12. Fujimoto WY, Bergstrom RW, Boyko EJ. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American community diabetes study. Diabetes Care 1999; 22: 1808-1812. Go to original source... Go to PubMed...
  13. Sharrett AR, Ballantyne CM, Coady SA, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-1113. Go to original source... Go to PubMed...
  14. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506. Go to original source... Go to PubMed...
  15. Reaven GM, Chen YD, Jeppesen J, et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Incest 1993; 92: 141-146. Go to original source... Go to PubMed...
  16. Kathiresan S, Otvos JD, Sullivan LM, et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006; 113: 20-29. Go to original source... Go to PubMed...
  17. Krauss RM, Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 1995; 62: 478S-487S. Go to original source... Go to PubMed...
  18. Dreon DM, Fernstrom HA, Williams PT, Krauss RM. A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr 1999; 69: 411-418. Go to original source... Go to PubMed...
  19. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 2265-2272. Go to original source... Go to PubMed...
  20. Dreon DM, Fernstrom HA, Williams PT, Krauss RM. LDL subclass patterns and lipoprotein response to a low-fat, highcarbohydrate diet in women. Arterioscler Thromb Vasc Biol 1997; 17: 707-714. Go to original source... Go to PubMed...
  21. Krauss RM, Blanche PJ, Rawlings RS, et al. Both low dietary carbohydrate and weight loss reduce expression of atherogenic lipoprotein phenotype. Circulation 2003; 108(suppl IV): IV-784.
  22. Krauss RM, Blanche PJ, Rawlings RS, et al. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr 2006; 83: 1025-1031. Go to original source... Go to PubMed...
  23. Moreno JA, Pe´rez-Jime´nez F, Mar?´n C, et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 2004; 134: 2517-2522. Go to original source... Go to PubMed...
  24. Kratz M, Gu¨lbahc¸e E, von Eckardstein A, et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr 2002; 132: 715-718. Go to original source... Go to PubMed...
  25. Rivellese AA, Maffettone A, Vessby B, et al. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Atherosclerosis 2003; 167: 149-158. Go to original source... Go to PubMed...
  26. Lai CQ, Corella D, Demissie S, et al. Dietary intake of ?-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 2006; 113: 2062-2070. Go to original source... Go to PubMed...
  27. Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155. Go to original source... Go to PubMed...
  28. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287:2414-2423. Go to original source... Go to PubMed...
  29. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic index, glycemic load, and chronic disease risk: a meta-analysis of observational studies. Am J Clin Nutr 2008; 87: 627-637. Go to original source... Go to PubMed...
  30. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-1499. Go to original source... Go to PubMed...
  31. Jakobsen MU, Overvad K, Dyerberg J, et al. Dietary fat and risk of coronary heart disease: possible effect modification by gender and age. Am J Epidemiol 2004; 160: 141-149. Go to original source... Go to PubMed...
  32. Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89: 1425-1432. Go to original source... Go to PubMed...
  33. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7: e1000252. Go to original source... Go to PubMed...
  34. Jakobsen MU, Dethlefsen C, Joensen AM, et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010; 91: 1764-1768. Go to original source... Go to PubMed...
  35. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 655-666. Go to original source... Go to PubMed...
  36. Mozaffarian D, Ludwig DS. Dietary guidelines in the 21st century: a time for food. JAMA 2010; 304: 681-682. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.